Lineage Cell Therapeutics 10K 2014 Annual report | LCTX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abbreviated, Abcodia, abstract, aesthetic, al, alleviate, alleviated, allotted, AMP, annum, arisen, attorney, Australian, automated, battery, BCF, big, biobank, biosimilar, bona, briefly, British, BSI, buying, Cao, capture, Carmichael, category, CER, chest, clearance, CMS, cohort, concomitant, contractor, contralateral, coordinate, CRT, CRUK, Cytopathology, deadline, Department, depict, DeVivo, Dimethyl, disburse, disbursement, DMSO, donut, dossier, dramatically, ELISPOT, embedded, Endeavor, Epithelium, excise, faculty, fide, fifty, fill, finder, focal, forecast, fovea, frame, franchise, freestanding, freezing, freight, GMCSF, gut, hardware, hEPSc, Hoboken, hole, Icahn, immunostimulatory, indemnity, influence, influenced, Inj, instrument, intradermal, intrinsic, Jeffrey, Jersey, Jose, Klita, Korean, leasehold, LeBuhn, lesion, Lichtinger, lifestyle, lipotransfer, LLP, locomotor, longitudinal, Los, macula, mandated, monolayer, Mount, movement, MRI, Mt, musculature, Myriad, nearer, neurotrophin, NGA, nitrogen, noncompliant, NSCLC, Ocata, Ocatatechnology, ocular, OfferingSM, official, older, ophthalmic, opposition, OUM, Ovarian, painlessly, Pedro, persuasive, pilot, placement, PLC, PMA, postage, premarket, prematurely, prerequisite, prescription, proactive, proration, quantify, quotation, randomized, rebate, refectory, reform, region, Rehabil, renegotiated, repay, resembling, revoked, Richard, role, rolling, San, SCF, School, SCIM, Secretary, sensorimotor, sharp, Shekel, Sinai, slowly, software, spot, spread, statute, subscore, successor, Sulfoxide, tetramer, thereon, thinning, tool, Top, UK, underwritten, uniform, unqualified, urology, user, vapor, VarElect, VEGF, velocity, verification, Vice, wearable, Yale

Removed: Abbott, Addendum, adding, alfred, ample, ampoule, appointed, Asian, assume, bad, budget, Bulletin, Burnham, Calculation, carryforward, Certificate, chemiluminescent, Chinese, chondrogenic, CLIA, complying, concert, congenital, cystic, deduction, deriving, digit, disorder, displayed, driven, duly, electronically, ELISA, Embryome, expandable, extension, faster, favor, forma, furnish, granulomata, Greenbelt, Hal, hemodynamically, hindered, hybridoma, identifiable, identifying, immuno, implantation, inapplicable, indemnitee, inherited, initiation, Instance, integration, Interactive, Judith, kidney, kingsley, kit, lawsuit, Linkbase, linked, LLC, lowest, maker, mark, marrow, Miami, misconduct, mouse, nation, negligence, nominal, noncontrolling, omitted, outbound, peabody, permanently, persist, pipeline, practicable, preceding, prominent, promotional, promulgated, pronouncement, provisional, pump, reactive, reagent, realization, reducing, reliable, renew, repayment, repurchase, resale, resell, resuscitation, robert, room, Ryder, scheduled, Schema, secrete, Segall, shipment, simplify, sixty, SKS, slightly, Specimen, steering, Sternberg, Street, successive, tangible, Taxonomy, Tew, thereto, thereunto, transcription, transportation, trustee, undersigned, unrelated, unsold, unstable, USCN, Washington, whatsoever, winding, XBRL

Subsidiary	BioTime Ownership	Country
Asterias Biotherapeutics, Inc.	67.5%	USA
BioTime Asia, Limited	81%	Hong Kong
Cell Cure Neurosciences Ltd.	62.5%(1)	Israel
ES Cell International Pte Ltd	100%	Singapore
LifeMap Sciences, Inc.	74.52%	USA
LifeMap Sciences, Ltd.	(2)	Israel
LifeMap Solutions, Inc.	(2)	USA
OncoCyte Corporation	75.3%	USA
OrthoCyte Corporation	100%(3)	USA
ReCyte Therapeutics, Inc.	94.8%	USA

Lineage Cell Therapeutics (LCTX) 10-K2014 FY Annual report

Content analysis